Pages that link to "Q42836618"
Jump to navigation
Jump to search
The following pages link to DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancer. (Q42836618):
Displaying 11 items.
- Pharmacological enhancement of memory or cognition in normal subjects (Q33659760) (← links)
- The likelihood of cognitive enhancement (Q35043146) (← links)
- AMPA receptor potentiators: from drug design to cognitive enhancement (Q35054673) (← links)
- AMPA receptor-positive allosteric modulators for the treatment of schizophrenia: an overview of recent patent applications (Q38421802) (← links)
- Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors (Q41491434) (← links)
- Synergistic enhancing-memory effect of donepezil and S 47445, an AMPA positive allosteric modulator, in middle-aged and aged mice (Q48592423) (← links)
- S 18986 reverses spatial working memory impairments in aged mice: comparison with memantine (Q51021896) (← links)
- TAK-137, an AMPA-R potentiator with little agonistic effect, has a wide therapeutic window (Q91411462) (← links)
- The application of electrophysiological methods to characterize AMPA receptors in dissociated adult rat and non-human primate cerebellar neurons for use in neuronal safety pharmacology assessments of the central nervous system (Q95930173) (← links)
- Allosteric modulation of AMPA receptors counteracts Tau-related excitotoxic synaptic signaling and memory deficits in stress- and Aβ-evoked hippocampal pathology (Q95936707) (← links)
- Acetylation of AMPA Receptors Regulates Receptor Trafficking and Rescues Memory Deficits in Alzheimer's Disease (Q99624207) (← links)